JRE PF US LP is raising an indefinite amount through an exempt securities offering, with $18,047,000 already sold. The Investment is identified as a Private Equity fund offering, giving investors a defined view of Capital raised so far even though the ultimate offering size remains indefinite.
Key Highlights
- The offering record lists 17 investors and a $300,000 minimum investment.
- JRE PF US LP is identified as a Delaware limited Partnership formed in 2022.
- JPMorgan Securities LLC is listed at 383 Madison Avenue, New York, New York 10,179.
JRE PF US LP has sold $18,047,000 through an exempt securities offering whose total size is listed as indefinite.
$18M Private Equity Offering Details
JRE PF US LP is registered at 124 East 14th Street, New York, New York 10,003, and is organized in Delaware as a limited partnership. The record identifies John Fraser, Alexander Mitzner and Brian Thomas as executive officers, with Georgina Camazza, Amy DiChiara and Shannon Lovetree serving as directors. JPMorgan Securities LLC is listed in connection with the offering at 383 Madison Avenue, New York, New York 10,179, with sales permitted in all states. The record lists 17 investors and a $300,000 minimum investment. The offering uses the exemptions identified as 06b, 3C and 3C.7.
FAQs
Q: How much has JRE PF US LP sold in its private equity offering?
A: JRE PF US LP has sold $18,047,000 through the exempt securities offering. The total offering amount is listed as indefinite.
Q: What type of investment vehicle is JRE PF US LP?
A: JRE PF US LP is identified as a pooled investment fund and private equity fund. Its legal structure is a Delaware limited partnership.
Q: Who is connected with the JRE PF US LP offering?
A: JPMorgan Securities LLC is listed in connection with the offering. The record names John Fraser, Alexander Mitzner and Brian Thomas as executive officers.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.